Free Trial

ProMIS Neurosciences (PMN) Short Interest Ratio & Short Volume

ProMIS Neurosciences logo
$1.00 +0.01 (+1.01%)
(As of 11/20/2024 ET)

ProMIS Neurosciences Short Interest Data

ProMIS Neurosciences (PMN) has a short interest of 239,800 shares, representing 1.16% of the float (the number of shares available for trading by the public). This marks a 74.02% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 88,686 shares to cover all short positions.

Current Short Interest
239,800 shares
Previous Short Interest
137,800 shares
Change Vs. Previous Month
+74.02%
Dollar Volume Sold Short
$304,546.00
Short Interest Ratio
3.5 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
32,690,000 shares
Float Size
20,660,000 shares
Short Percent of Float
1.16%
Today's Trading Volume
41,054 shares
Average Trading Volume
88,686 shares
Today's Volume Vs. Average
46%
Short Selling ProMIS Neurosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ProMIS Neurosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PMN Short Interest Over Time

PMN Days to Cover Over Time

PMN Percentage of Float Shorted Over Time

ProMIS Neurosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024239,800 shares $304,546.00 +74.0%1.2%3.5 $1.27
10/15/2024137,800 shares $143,312.00 +7.7%0.6%0.8 $1.04
9/30/2024128,000 shares $160,000.00 -12.0%0.6%0.8 $1.25
9/15/2024145,400 shares $178,842.00 +12.9%0.6%1 $1.23
8/31/2024128,800 shares $175,966.56 +14.5%0.6%0.9 $1.37
8/15/2024112,500 shares $137,812.50 +1.3%0.6%0.9 $1.23
7/31/2024111,100 shares $159,428.50 +319.3%0.9%0.9 $1.44
7/15/202426,500 shares $56,445.00 +72.1%0.2%3.8 $2.13
6/30/202415,400 shares $23,100.00 +43.9%0.1%1.8 $1.50
6/15/202410,700 shares $17,262.31 +64.6%0.1%1.1 $1.61
5/31/20246,500 shares $11,973.00 -4.4%0.1%0.6 $1.84
5/15/20246,800 shares $12,240.00 -10.5%0.1%0.5 $1.80
4/30/20247,600 shares $15,223.56 -67.1%0.1%0.5 $2.00
4/15/202423,100 shares $50,127.00 -2.9%0.2%1.2 $2.17
3/31/202423,800 shares $45,458.00 -0.8%0.2%0.6 $1.91
3/15/202424,000 shares $45,840.00 +21.8%0.4%0.5 $1.91
2/29/202419,700 shares $41,173.00 +7.1%0.3%0.4 $2.09
2/15/202418,400 shares $35,880.00 -33.1%0.3%0.4 $1.95
1/31/202427,500 shares $55,000.00 No Change0.4%0.6 $2.00
6/15/2023200 shares $984.00 -33.3%N/A0.1 $4.92
5/31/2023300 shares $1,467.39 No ChangeN/A0.1 $4.89
5/15/2023300 shares $1,764.00 No ChangeN/A0.1 $5.88

PMN Short Interest - Frequently Asked Questions

What is ProMIS Neurosciences' current short interest?

Short interest is the volume of ProMIS Neurosciences shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 239,800 shares of PMN short. 1.16% of ProMIS Neurosciences' shares are currently sold short. Learn More on ProMIS Neurosciences' current short interest.

What is a good short interest ratio for ProMIS Neurosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMN shares currently have a short interest ratio of 4.0. Learn More on ProMIS Neurosciences's short interest ratio.

What is a good short interest percentage for ProMIS Neurosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.16% of ProMIS Neurosciences' floating shares are currently sold short.

Is ProMIS Neurosciences' short interest increasing or decreasing?

ProMIS Neurosciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 239,800 shares, an increase of 74.0% from the previous total of 137,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ProMIS Neurosciences' float size?

ProMIS Neurosciences currently has issued a total of 32,690,000 shares. Some of ProMIS Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProMIS Neurosciences currently has a public float of 20,660,000 shares.

How does ProMIS Neurosciences' short interest compare to its competitors?

1.16% of ProMIS Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ProMIS Neurosciences: Skye Bioscience, Inc. (8.88%), Candel Therapeutics, Inc. (9.04%), Adverum Biotechnologies, Inc. (13.39%), Cardiff Oncology, Inc. (15.78%), Incannex Healthcare Inc. (0.38%), Cidara Therapeutics, Inc. (1.05%), Compugen Ltd. (1.42%), Outlook Therapeutics, Inc. (21.21%), Cardiol Therapeutics Inc. (1.23%), Ventyx Biosciences, Inc. (14.88%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short ProMIS Neurosciences stock?

Short selling PMN is an investing strategy that aims to generate trading profit from ProMIS Neurosciences as its price is falling. PMN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ProMIS Neurosciences?

A short squeeze for ProMIS Neurosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMN, which in turn drives the price of the stock up even further.

How often is ProMIS Neurosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMN, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:PMN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners